Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer

The role of PD-L1 as a prognostic and predictive biomarker is an area of great interest. However, there is a lack of consensus on how to deliver PD-L1 as a clinical biomarker. At the heart of this conundrum is the subjective scoring of PD-L1 IHC in most studies to date. Current standard scoring syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphries, Matthew P., Hynes, Sean, Bingham, Victoria, Cougot, Delphine, James, Jacqueline, Patel-Socha, Farah, Parkes, Eileen E., Blayney, Jaine K., O'Rorke, Michael A., Irwin, Gareth W., McArt, Darragh G., Kennedy, Richard D., Mullan, Paul B., McQuaid, Stephen, Salto-Tellez, Manuel, Buckley, Niamh E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311859/
https://www.ncbi.nlm.nih.gov/pubmed/30651729
http://dx.doi.org/10.1155/2018/2937012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311859/
https://www.ncbi.nlm.nih.gov/pubmed/30651729
http://dx.doi.org/10.1155/2018/2937012

Ejemplares similares